Skip to main content
SpringerLink
Log in

Patch Testing in Adverse Drug Reactions

  • Chapter
Contact Dermatitis

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bruynzeel DP, Maibach HI (1997) Patch testing in systemic drug eruptions. Clin Dermatol 15:479–484

    Article  PubMed  CAS  Google Scholar 

  2. Roujeau JC (1997) Drug-induced skin reactions. In: Grobb JJ, Stern RS, Mac Kie RM, Weinstock WA (eds) Epidemiology, causes and prevention of skin diseases. Blackwell, Oxford, UK

    Google Scholar 

  3. Bigby M (2001) Rates of cutaneous reactions to drugs. Arch Dermatol 137:765–770

    PubMed  CAS  Google Scholar 

  4. Menné T, Maibach HI (1966) Systemic contact-type dermatitis. In: Marzulli FN, Maibach HI (eds) Dermatoxicology, 5th edn. Taylor and Francis, Washington, DC, pp 161–175

    Google Scholar 

  5. Pichler WJ, Schnyder B, Zanni MP, Hari Y, von Greyerz S (1998) Role of T cells in drug allergies. Allergy 53:225–232

    PubMed  CAS  Google Scholar 

  6. Pichler W (2003) Delayed drug hypersensitivity reactions. Ann Intern Med 139:683–693

    PubMed  CAS  Google Scholar 

  7. Griem P, Wulferink M, Sachs B, González JB, Gleichmann E (1998) Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today 19:133–141

    Article  PubMed  CAS  Google Scholar 

  8. Hari Y, Fruitig-Schnyder K, Hurni M, Yawalker N, Zanni MP, Schnyder B, Kappeler A, von Greyerz S, Braathen LR, Pichler WJ (2001) T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 31:1398–1408

    Article  PubMed  CAS  Google Scholar 

  9. Barbaud A, Gonçalo M, Bruynzeel D, Bircher A (2001) Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 45:321–328

    Article  PubMed  CAS  Google Scholar 

  10. Kallós P, Kallós L (1980) Histamine and some other mediators of pseudo-allergic reactions. In: Dukor P, Kallós P, Schlumberger HD, West GB, (eds) PAR. Pseudo-allergic reactions, vol 1: genetic aspects and anaphylactoid reactions. Karger, Basel, Switzerland, pp 28–55

    Google Scholar 

  11. Bruynzeel DP, von Blomberg-van der Flier M, Scheper RJ, van Ketel WG, de Haan P (1985) Allergy for penicillin and the relevance of epicutaneous tests. Dermatologica 171:429–434

    PubMed  CAS  Google Scholar 

  12. Yawalker N, Hari Y, Frutig K, Egli F, Wendland T, Braathen LR, Pichler WJ (2000) T cells isolated from positive epicutaneous test reactions to amoxicillin and ceftriaxone are drug specific and cytotoxic. J Invest Dermatol 115:647–652

    Article  Google Scholar 

  13. Barbaud A (2002) Tests cutanés dans l’investigation des toxidermies: de la physiopathologie aux résultats des investigations. Thérapie 57:258–262

    PubMed  CAS  Google Scholar 

  14. Kuechler PC, Britschgi M, Schmid S, Hari Y, Grabscheid B, Pichler WJ (2004) Cytotoxic mechanisms in different forms of T-cell-mediated drug allergies. Allergy 59:613–622

    Article  PubMed  CAS  Google Scholar 

  15. Britschgi M, Pichler WJ (2002) Acute generalized exanthematous pustulosis, a clue to neutrophil-mediated inflammatory processes orchestrated by T cells. Curr Opin Allergy Clin Immunol 2:325–331

    Article  PubMed  Google Scholar 

  16. Choquet-Kastylevsky G, Intrator L, Chenal C, Bocquet H, Revuz J, Roujeau JC (1998) Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome. Br J Dermatol 139:1026–1032

    Article  PubMed  CAS  Google Scholar 

  17. Gonçalo M, Oliveira HS, Fernandes B, Robalo-Cordeiro M, Figueiredo A (2002) Topical provocation in fixed drug eruption from nonsteroidal anti-inflammatory drugs. Exogenous Dermatol 1:81–86

    Article  Google Scholar 

  18. Gonçalo M (1998) Exploration dans les photo-allergies médicamenteuses. In: Groupe d’Etudes et de Recherches en Dermato-Allergologie (GERDA) (eds) Progrès en dermato-allergologie. John Libbey Eurotext, Nancy, France, pp 67–74

    Google Scholar 

  19. Gonçalo M, Figueiredo A, Tavares P, Fontes Ribeiro CA, Teixeira F, Poiares Baptista A (1992) Photosensitivity to piroxicam: absence of cross reaction with tenoxicam. Contact Dermatitis 27:287–290

    Article  PubMed  Google Scholar 

  20. Moore N, Paux G, Begaud B, Biour M, Loupi E, Boismare F, Royer RJ (1985) Adverse drug reaction monitoring: doing it the French way. Lancet 2:1056–1058

    Article  PubMed  CAS  Google Scholar 

  21. Pietzcker F, Kuner V (1975) Anaphylaxie nach epicutanem Ampicillin-Test. Z Hautkr 50:437–440

    PubMed  CAS  Google Scholar 

  22. Maucher OM (1972) Anaphylaktische Reaktionen beim Epicutantest. Hautarzt 23:139–140

    PubMed  CAS  Google Scholar 

  23. Shechter JF, Wilkinson RD, dei Carpio J (1984) Anaphylaxis following the use of bacitracin ointment. Report of a case and review of the literature. Arch Dermatol 120:909–911

    Article  Google Scholar 

  24. Jonker MJ, Bruynzeel DP (2003) Anaphylactic reaction elicited by patch testing with diclofenac. Contact Dermatitis 49:114–115

    Article  PubMed  Google Scholar 

  25. Mashiah J (2003) A systemic reaction to patch testing for the evaluation of acute generalized exanthematous pustulosis. Arch Dermatol 139:1181–1183

    Article  PubMed  Google Scholar 

  26. Osawa J, Naito S, Aihara M, Kitamura K, Ikezawa Z, Nakajima H (1990) Evaluation of skin test reactions in patients with non-immediate type drug eruptions. J Dermatol 17:235–239

    PubMed  CAS  Google Scholar 

  27. Barbaud A, Reichert-Penetrat S, Tréchot P, Jaquin-Petit M-A, Ehlinger A, Noirez V, Faure GC, Schmutz J-L, Béné M-C (1998) The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 139:49–58

    Article  PubMed  CAS  Google Scholar 

  28. Gonçalo M, Fernandes B, Oliveira HS, Figueiredo A (2000) Epicutaneous patch testing in drug eruptions. Contact Dermatitis 42:22

    Google Scholar 

  29. Barbaud A, Tréchot P, Weber-Muller F, Ulrich G, Coomun N, Schmutz J-L (2004) Drug skin tests in cutaneous adverse drug reactions to pristinamycin: 29 cases with a study of cross-reactions between synergistins. Contact Dermatitis 50:22–26

    Article  PubMed  CAS  Google Scholar 

  30. Camarasa JG, Serra-Baldrich E (1990) Tetrazepam allergy detected by patch test. Contact Dermatitis 22:246

    Article  PubMed  CAS  Google Scholar 

  31. Reichert C, Gall H (1998) Type-IV-Allergie auf Tetrazepam. Dermatosen 46:75–78

    Google Scholar 

  32. Ortega NR, Barranco P, López Serrano C, Romualdo L, Mora C (1996) Delayed cell-mediated hypersensitivity to tetrazepam. Contact Dermatitis 34:139

    Article  PubMed  CAS  Google Scholar 

  33. Ortiz-Frutos FJ, Alonso J, Hergueta JP, Quintana I, Iglesias L (1995) Tetrazepam: an allergen with several clinical expressions. Contact Dermatitis 33:63–65

    Article  PubMed  CAS  Google Scholar 

  34. Alanko K (1993) Patch testing in cutaneous reactions caused by carbamazepine. Contact Dermatitis 29:254–257

    Article  PubMed  CAS  Google Scholar 

  35. Camarasa JG (1985) Patch test diagnosis of exfoliative dermatitis due to carbamazepine. Contact Dermatitis 12:49

    Article  PubMed  CAS  Google Scholar 

  36. Puig L, Nadal C, Fernández-Figueras M-T, Alomar A (1996) Carbamazepine-induced drug rashes: diagnostic value of patch tests depends on clinico-pathologic presentation. Contact Dermatitis 34:435–437

    Article  PubMed  CAS  Google Scholar 

  37. Renn CN, Straff W, Dorfmüller A, Al-Masoudi T, Merk HF, Sachs B (2002) Amoxicillin-induced exanthema in young adults with infectious mononucleosis: demonstration of drug-specific lymphocyte reactivity. Brit J Dermatol 147:1166–1170

    Article  CAS  Google Scholar 

  38. Alanko K (1994) Topical provocation of fixed drug eruption. A study of 30 patients. Contact Dermatitis 31:25–27

    Article  PubMed  CAS  Google Scholar 

  39. Ozkaya-Bayazit E, Güngôr H (1997) Trimethopriminduced fixed drug eruption: positive topical provocation on previously involved and uninvolved skin. Contact Dermatitis 39:87–88

    Google Scholar 

  40. Oliveira HS, Gonçalo M, Figueiredo A (2000) Photosensitivity to lomefloxacin. A clinical and photobiological study. Photodermatol Photoimmunol Photomedic 16:116–120

    Article  CAS  Google Scholar 

  41. Bruynzeel DP, van Ketel WG (1989) Patch testing in drug eruptions. Semin Dermatol 8:196–203

    PubMed  CAS  Google Scholar 

  42. Fellner MJ (1968) An immunologic study of selected penicillin reactions involving the skin. Arch Dermatol 96:503–519

    Article  Google Scholar 

  43. Klein CE, Trautmann A, Zillikens D, Bröcker EB (1995) Patch testing in an unusual case of toxic epidermal necrolysis. Contact Dermatitis 33:448–449

    Article  PubMed  CAS  Google Scholar 

  44. Barbaud A, Tréchot P, Reichert-Pénétrat S, Granel F, Schmutz JL (2001) The usefulness of patch testing on the previously most severely affected site in a cutaneous adverse drug reaction to tetrazepam. Contact Dermatitis 44:259–260

    PubMed  CAS  Google Scholar 

  45. Torres M-J, Sanchez-Sabaté E, Alvarez J, Mayorga C, Fernández J, Padial A, Cornejo-Garcia J-A, Bellón T, Blanca M (2004) Skin test evaluation in nonimmediate allergic reactions to penicillins. Allergy 59:219–234

    Article  PubMed  CAS  Google Scholar 

  46. Gonçalo M, Oliveira S, Monteiro C, Clerins I, Figueiredo A (1999) Allergic and systemic contact dermatitis from estradiol. Contact Dermatitis 40:58–59

    PubMed  Google Scholar 

  47. Le Coz CJ, Bottleander A, Scrivener J-N, Santinelli F, Cribier BJ, Heid E, Grosshans EM (1998) Photocontact dermatitis from ketoprofen and tiaprofenic acid: crossreactivity study in 12 consecutive patients. Contact Dermatitis 38:245–252

    PubMed  Google Scholar 

  48. Shmunes E (1984) Allergic dermatitis to benzyl alcohol in an injectable solution. Arch Dermatol 120:1200–1201

    Article  PubMed  CAS  Google Scholar 

  49. Schäfer T, Enders F, Przybilla B (1995) Sensitization to thimerosal and previous vaccination. Contact Dermatitis 32:114–116

    Article  PubMed  Google Scholar 

  50. Verecken P. Birringer C, Knitelius A-C, Herbaut D, Germaux M-A (1998) Sensitization to benzyl alcohol: a possible cause of “corticosteroid allergy”. Contact Dermatitis 38:106

    PubMed  CAS  Google Scholar 

  51. Barbaud A, Tréchot P, Reichert-Penetrat S, Commun N, Schmutz JL (2001) Relevance of skin tests with drugs in investigating cutaneous adverse drug reactions. Contact Dermatitis 45:265–268

    Article  PubMed  CAS  Google Scholar 

  52. van Ketel WG (1975) Patch testing in penicillin allergy. Contact Dermatitis 1:253–254

    Article  PubMed  Google Scholar 

  53. Vieira R, Gonçalo M, Figueiredo A (2004) Patch testing with allopurinol and oxypurinol in drug eruptions. Contact Dermatitis 50:156

    Article  Google Scholar 

  54. Hannuksela M (1998) Skin testing in drug hypersensitivity. In: Kauppinen K, Alanko K, Hannuksela M, Maibach H (eds) Skin reactions to drugs. CRC, Boca Raton, Fla., pp 81–95

    Google Scholar 

  55. Alanko K, Kauppinen K (1998) Diagnosis of drug eruptions: clinical evaluation and drug challenge. In: Kauppinen K, Alanko K, Hannuksela M, Maibach H (eds) Skin reactions to drugs. CRC, Boca Raton, Fla., pp 75–79

    Google Scholar 

  56. Kawada A, Hiruma M, Miura Y, Noguchi H, Akiyama M, Ishibashi A (1997) Photosensitivity due to actarit. Contact Dermatitis 36:175–176

    Article  PubMed  CAS  Google Scholar 

  57. Suhonen R (1976) Thioridazine photosensitivity. Contact Dermatitis 2:179

    Article  PubMed  CAS  Google Scholar 

  58. Schwarze HP, Albes B, Marguery MC, Loche F, Bazex J (1998) Evaluation of drug-induced photosensitivity by UVB photopatch testing. Contact Dermatitis 39:200

    PubMed  CAS  Google Scholar 

  59. Sandra A, Srinivas CR, Deshpande SC (1998) Photopatch test reaction to amitriptyline. Contact Dermatitis 39:208–209

    PubMed  CAS  Google Scholar 

  60. Terni T, Tagami H (1989) Eczematous drug eruption from carbamazepine: coexistence of contact and photocontact sensitivity. Contact Dermatitis 20:260–264

    Article  Google Scholar 

  61. Ljunggren B, Bos G (1991) A case of photosensitivity and contact allergy to systemic tricyclic drugs, with unusual features. Contact Dermatitis 24:259–265

    Article  PubMed  CAS  Google Scholar 

  62. van Weelden H, Bolling HH, Baart de la Faille H, van der Leun JC (1982) Photosensitivity caused by chloroquine. Arch Dermatol 118:290

    Article  PubMed  Google Scholar 

  63. Tanaka N, Kawada A, Ohnishi Y, Hiruma M, Tajima S, Akiyama M, Ishibashi A (1997) Photosensitivity due to doxycycline hydrochloride with an unusual flare. Contact Dermatitis 37:93–94

    Article  PubMed  CAS  Google Scholar 

  64. Vilaplana J, Romaguera C, Azón A, Lecha M (1998) Flutamide photosensitivity — residual vitiliginous lesions. Contact Dermatitis 38:68–70

    PubMed  CAS  Google Scholar 

  65. Martín-Lázaro J, Buján JG, Arrondo AP, Lozano JR, Galindo EC, Capdevila EF (2004) Is photopatch testing useful in the investigation of photosensitivity due to flutamide? Contact Dermatitis 50:325–326

    Article  PubMed  Google Scholar 

  66. Kojima T, Hasegawa T, Ishida H, Fujita M, Okamoto S (1988) Griseofulvin-induced photodermatitis — report of six cases. J Dermatol 15:76–82

    PubMed  CAS  Google Scholar 

  67. Gonçalo M, Barros MA, Azenha A, Basto S, Figueiredo A (1996) The importance of photopatch testing in patients with photosensitive drug eruptions. In: Jadassohn Centenary Congress abstract book. European Society of Contact Dermatitis (ESCD), London, p 15

    Google Scholar 

  68. Kurumajin Y, Shono M (1992) Scarified photopatch testing in lomefloxacin photosensitivity. Contact Dermatitis 26:5–10

    Article  Google Scholar 

  69. Przybilla B, Ring J, Scwab U, Galosi A, Dom M, Braun-Falco O (1987) Photosensibilisierende Eigenschaften nichtsteroidaler Antirheumatika im Photopatch-Test. Hautarzt 38:18–25

    PubMed  CAS  Google Scholar 

  70. Kurumaji Y (1996) Ampiroxicam-induced photosensitivity. Contact Dermatitis 34:298–299

    Article  PubMed  CAS  Google Scholar 

  71. Vasconcelos C, Magina S, Quirino P, Barros MA, Mesquita-Guimaräes J (1997) Cutaneous drug reactions to piroxicam. Contact Dermatitis 39:145

    Google Scholar 

  72. Varela P, Amorim I, Massa A, Sanches M, Silva E (1998) Piroxicam-beta-cyclodextrin and photosensitivity reactions. Contact Dermatitis 38:229

    PubMed  CAS  Google Scholar 

  73. Youn JL, Lee HG, Yeo UC, Lee YS (1993) Piroxicam photosensitivity associated with vesicular hand dermatitis. Clin Exp Dermatol 18:52–54

    Article  PubMed  CAS  Google Scholar 

  74. Figueiredo A, Fontes Reibeiro CA, Gonçalo S, Caldeira HM, Poiares-Baptista A, Teixeiro F (1987) Piroxicaminduced photosensitivity. Contact Dermatitis 17:73–79

    Article  PubMed  CAS  Google Scholar 

  75. Morimoto K. Kawada A, Hiruma M, Ishibashi A (1996) Photosensitivity from pyridoxine hydrochloride (vitamin B6). J Am Acad Dermatol 35:304–305

    Article  PubMed  CAS  Google Scholar 

  76. Ishibashi A, Hirano K. Nishiyama Y (1973) Photosensitive dermatitis due to pyritinol. Arch Dermatol 107:427–428

    Article  PubMed  CAS  Google Scholar 

  77. Ljunggren B, Hindesen M, Isaksson (1992) Systemic quinine photosensitivity with photoepicutaneous crossreactivity to quinidine. Contact Dermatitis 26:1–4

    Article  PubMed  CAS  Google Scholar 

  78. Kimura M, Kawada A (1998) Photosensitivity induced by lomefloxacin with cross-photosensitivity to ciprofloxacin and fleroxacin. Contact Dermatitis 38:180

    PubMed  CAS  Google Scholar 

  79. Morimoto K, Kawada A, Hiruma M, Ishibashi A, Banda H (1995) Photosensitivity to simvastatin with an unusual response to photopatch and photo tests. Contact Dermatitis 33:274

    Article  PubMed  CAS  Google Scholar 

  80. Rodriguez Granados MT, De La Torre C, Cruces MJ, Pifteiro G (1998) Chronic actinic dermatitis due to simvastatin. Contact Dermatitis 38:294–295

    Google Scholar 

  81. Quiftones D, Sanchez I, Garcia-Abujeta JL, Fernandez L, Rodriguez F, Martil-Gil D, Jerez J (1998) Photodermatitis from tetrazepam. Contact Dermatitis 39:84

    Google Scholar 

  82. Serrano G, Aliaga A, Planells I (1987) Photosensitivity associated with triflusal (Disgren). Photodermatology 4:103–105

    PubMed  CAS  Google Scholar 

  83. Ruzicka T, Gerstmeier M, Przybilla B, Ring J (1987) Allergy to local anesthetics: comparison of patch test with prick and intradermal test results. J Am Acad Dermatol 16:1202–1208

    Article  PubMed  CAS  Google Scholar 

  84. van Joost T, Sillevis Smitt JH (1981) Skin reactions to propranolol and cross-sensitivity to beta-adrenoreceptor blocking agents. Arch Dermatol 117:600–601

    Article  PubMed  Google Scholar 

  85. Romano A, Di Fonso M, Pietrantonio F, Pocobelli D, Giannarini L, Dei Bono A, Fabrizi G, Venuti A (1993) Repeated patch testing in delayed hypersensitivity to beta-lactam antibiotics. Contact Dermatitis 28:190

    Article  PubMed  CAS  Google Scholar 

  86. Lisi P, Lapomarda V, Stingeni L, Assalve D, Handel K, Caraffini S, Agostinelli D (1997) Skin tests in the diagnosis of eruptions caused by betalactams. Contact Dermatitis 37:151–154

    Article  PubMed  CAS  Google Scholar 

  87. Moreno-Ancillo A, Dominguez-Noche C, Gil-Adrados AC, Cosmes PM (2003) Near-fatal delayed hypersensitivity reaction to cloxacillin. Contact Dermatitis 49:44–49

    Article  PubMed  Google Scholar 

  88. Kämpgen E, Bürger T, Bröcker E-V, Klein E (1995) Crossreactive type IV hypersensitivity reactions to benzodiazepines revealed by patch testing. Contact Dermatitis 33:356–357

    Article  PubMed  Google Scholar 

  89. Pirker C, Misic A, Brinkmeier T, Frosch PJ (2002) Tetrazepam drug sensitivity — usefulness of the patch test. Contact Dermatitis 47:135–138

    Article  PubMed  CAS  Google Scholar 

  90. Kimura M, Kawada A (1998) Drug eruption due to bucillamine. Contact Dermatitis 39:98–99

    PubMed  CAS  Google Scholar 

  91. Prieto López C, Gamboa PM, Zugazaga Prieto M, Fernández Martínez JC, Miguel de la Villa F, Antépara Ercoreca I (1990) Study of various immunological parameters in the diagnosis of allergy to penicillin G and its derivatives. Allergol Immunpathol 18:141–148

    Google Scholar 

  92. Smit AJ, Van der Laan S, De Monchy J, Kallenberg CGM, Donker AJM (1984) Cutaneous reactions to captopril. Predictive value of skin tests. Clin Allergy 14:413–419

    Article  PubMed  CAS  Google Scholar 

  93. Alonso JC, Ortega JD, Gonzalo MJ (2004) Cutaneous reaction to oral celecoxib with positive patch test. Contact Dermatitis 50:48–49

    Article  PubMed  Google Scholar 

  94. Galindo Bonilla PA, Garcia Rodríguez R, Feo Brito F, Garrido Martin JA, Fernández Martinez F (1994) Patch testing for allergy to beta-lactam antibiotics. Contact Dermatitis 31:319–320

    Article  PubMed  CAS  Google Scholar 

  95. Romano A, Pietrantonio F, di Fonso M, Venuti A (1992) Delayed hypersensitivity to cefuroxime. Contact Dermatitis 27:270–271

    Article  PubMed  CAS  Google Scholar 

  96. Filipe P, Silva R, Almeida S, Guerra Rodrigo F (1996) Occupational allergic contact dermatitis from cephalosporins. Contact Dermatitis 34:226

    Article  PubMed  CAS  Google Scholar 

  97. Peters K (1986) Delayed hypersensitivity to oral cimetidine. Contact Dermatitis 15:190–191

    Article  PubMed  CAS  Google Scholar 

  98. Mufioz D, dei Pozo MD, Audícana M, Fernández E, Fernandez de Corres L (1996) Erythema-multiforme-like eruption from antibiotics of 3 different groups. Contact Dermatitis 34:227–228; 20:72–73

    Article  Google Scholar 

  99. Lammintausta K, Tokola R, Kalimo K (2002) Cutaneous adverse reactions to clindamycin: results of skin tests and oral exposure. Br J Dermatol 146:643–648

    Article  PubMed  CAS  Google Scholar 

  100. de Groot AC, Conemans I (1986) Allergic urticarial rash from oral codeine. Contact Dermatitis 14:209–214

    Article  PubMed  Google Scholar 

  101. Moreau A, Dompmartin A (1995) Drug-induced acute generalized exanthematous pustulosis with positive patch tests. Int J Dermatol 34:263–266

    PubMed  CAS  Google Scholar 

  102. Wolkenstein P, Chosidow O, Fléchet M-L, Robbiola O, Paul M, Dumé L, Revuz J, Roujeau J-C (1996) Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 35:234–236

    Article  PubMed  CAS  Google Scholar 

  103. Wakelin SH, James MP (1995) Diltiazem-induced acute generalised exanthematous pustulosis. Clin Exp Dermatol 20:341–344

    Article  PubMed  CAS  Google Scholar 

  104. Audicana M, Urrutia I, Echechipia S, Mufioz D, Fernandez de Corres L (1991) Sensitization to ephedrine in oral anticatarrhal drugs. Contact Dermatitis 24:223

    PubMed  CAS  Google Scholar 

  105. Fernadez Redondo V, Casas L, Taboada M, Toribio J (1994) Systemic contact dermatitis from erythromycin. Contact Dermatitis 30:43–44

    Article  Google Scholar 

  106. Bircher AJ (1993) Allergische Reaktionen vom Spättyp auf Heparine. Allergologie 16:268–274

    Google Scholar 

  107. Bircher AJ, Flückiger R, Buchner SA (1990) Eczematous infiltrated plaques to subcutaneous heparin: a type IV allergic reaction. Br J Dermatol 123:507–514

    Article  PubMed  CAS  Google Scholar 

  108. Boehncke W-H, Weber L, Gall H (1996) Tolerance to intravenous administration of heparin and heparinoid in a patient with delayed-type hypersensitivity to heparins and heparinoids. Contact Dermatitis 35:73–75

    Article  PubMed  CAS  Google Scholar 

  109. Koch P, Hindi S, Landwehr D (1996) Delayed allergic skin reactions due to subcutaneous heparin-calcium, enoxaparin-sodium, pentosan polysulfate and acute skin lesions from systemic sodium-heparin. Contact Dermatitis 34:156–158

    Article  PubMed  CAS  Google Scholar 

  110. De Cuyper C, Goeteyn M (1992) Systemic contact dermatitis from subcutaneous hydromorphone. Contact Dermatitis 27:220–223

    Article  PubMed  Google Scholar 

  111. Machet L, Jan V, Machet MC, Lorette G, Vaillan L (1997) Acute generalized exanthematous pustulosis induced by nifuroxazide. Contact Dermatitis 36:308–309

    Article  PubMed  CAS  Google Scholar 

  112. Kiec-Swierczynska M, Krecisz B (1998) Occupational contact allergy to nifuroxazide simulating prurigo nodularis. Contact Dermatitis 39:93–94

    PubMed  CAS  Google Scholar 

  113. Quirce S, Farra F, Lázaro M, Gómez MI, Sánchez Cano M (1991) Generalized dermatitis due to oral nystatin. Contact Dermatitis 25:197–198

    Article  PubMed  CAS  Google Scholar 

  114. Fernández de Corres L, Bernaola G, Lobera T, Leanizbarrutia I, Mufioz D (1986) Allergy from pyrazolone derivatives. Contact Dermatitis 14:249–250

    Article  PubMed  Google Scholar 

  115. Valsecchi R, Tornaghi A, Falgheri G, Rossi A, Cainelli T (1983) Drug reaction from oxyphenbutazone. Contact Dermatitis 9:419

    Article  PubMed  CAS  Google Scholar 

  116. Haneke EG, Körner E, Haneke E (1980) Klinische Bedeutung positiver Penicillinreaktione. Dtsch Med Wochenschr 105:635–639

    Article  PubMed  CAS  Google Scholar 

  117. Landwehr AJ, van Ketel WG (1982) Delayed-type allergy to phenazone in a patient with erythema multiforme. Contact Dermatitis 8:283–284

    Article  PubMed  CAS  Google Scholar 

  118. Vooys RC, van Ketel WG (1977) Allergic drug eruption from pyrazolone compounds. Contact Dermatitis 3:57–58

    Article  PubMed  CAS  Google Scholar 

  119. Schätzle M, Agathos M, Breit R (1998) Allergic contact dermatitis from goldenrod (Herba solidaginis) after systemic administration. Contact Dermatitis 39:271–272

    PubMed  Google Scholar 

  120. De Boer EM, Bruynzeel DP (1994) Allergy to pravastatin. Contact Dermatitis 30:238

    Article  PubMed  Google Scholar 

  121. Gebhardt M, Lustig A, Bocker T, Wollina U (1995) Acute generalized exanthematous pustulosis (AGEP): manifestation of drug allergy to propicillin. Contact Dermatitis 33:204–205

    Article  PubMed  CAS  Google Scholar 

  122. Goday I, Aguirre A, Díaz-Pérez JL (1990) A positive patch test in a pyrazinamide drug eruption. Contact Dermatitis 22:181–182

    Article  PubMed  CAS  Google Scholar 

  123. Juste S, Blanco J, Garcés M, Rodriguez G (1992) Allergic dermatitis due to oral ranitidine. Contact Dermatitis 27:339–340

    Article  PubMed  CAS  Google Scholar 

  124. Fernandes B, Brites M, Gonçalo M, Figueiredo A (2000) Maculopapular eruption from sertraline with positive patch tests. Contact Dermatitis 42:287

    PubMed  CAS  Google Scholar 

  125. Romano A, Pietrantonio F, di Fonso M, Pocobelli D, Venuti A (1993) Delayed hypersensitivity to stepronin: a case report. Contact Dermatitis 29:166

    Article  PubMed  CAS  Google Scholar 

  126. Romano A, Pietrantonio F, di Fonso M, Venuti A, Fabrizi G (1995) Contact allergy to tiopronin: a case report. Contact Dermatitis 33:269

    Article  PubMed  CAS  Google Scholar 

  127. Bruynzeel I, Hebeda CL, Folkers E, Bruynzeel DP (1995) Cutaneous hypersensitivity reactions to vitamin K: 2 case reports and a review of the literature. Contact Dermatitis 32:78–82

    Article  PubMed  CAS  Google Scholar 

  128. Galindo PA, Garrido IA, Gómez E, Borja J, Feo F, Encinas C, García R (1998) Zinc acexamate allergy. Contact Dermatitis 38:301–302

    PubMed  CAS  Google Scholar 

  129. Montoro J, Basomba A (1997) Fixed drug eruption due to acyclovir. Contact Dermatitis 36:225

    Article  PubMed  CAS  Google Scholar 

  130. Lee AY (1998) Topical provocation in 31 cases of fixed drug eruption: change of causative drugs in 10 years. Contact Dermatitis 38:258–260

    PubMed  CAS  Google Scholar 

  131. Sugiura M, Hayakawa R, Osada T (1998) Fixed drug eruption due to amlexanox. Contact Dermatitis 38:65–67

    PubMed  CAS  Google Scholar 

  132. Gonzales Delgado P, Florido Lopez F, Saenz de San Pedro B (1995) Fixed drug eruption due to citiolone. Contact Dermatitis 33:352

    Article  Google Scholar 

  133. Rodriguez-Morales A, Alonso Llamazares A, Palacios Benito R, Martinez Cocera C (2001) Fixed drug eruption from quinolones with a positive lesional patch test to ciprofloxacin. Contact Dermatitis 44:255

    Article  PubMed  CAS  Google Scholar 

  134. Rosina P, Chieregato C, Schena D (1998) Fixed drug eruption from clarithromycin. Contact Dermatitis 38:105

    PubMed  CAS  Google Scholar 

  135. Kawada A, Hiruma M, Noguchi H, Akagi A, Ishibashi A, Marshall I (1996) Fixed drug eruption induced by ethenzamide. Contact Dermatitis 34:369–370

    Article  PubMed  CAS  Google Scholar 

  136. Gastaminez G, Anda M, Audicana MT, Fernandez E, Munoz D (2001) Fixed-drug eruption due to metronidazole with positive topical provocation. Contact Dermatitis 44:36

    Article  Google Scholar 

  137. Cordeiro MR, Gonçalo M, Fernandes B, Oliveira HS, Figueiredo A (2000) Positive lesional patch tests in fixed drug eruptions from nimesulide. Contact Dermatitis 43:307

    PubMed  CAS  Google Scholar 

  138. Kawada A, Hiruma M, Noguchi H, Banba K, Ishibashi A, Banba H, Marshall J (1996) Fixed drug eruption induced by ofloxacin. Contact Dermatitis 34:427

    Article  PubMed  CAS  Google Scholar 

  139. Oliveira HS, Gonçalo M, Reis JP, Figueiredo A (1999) Fixed drug eruption to piroxicam. Positive patch tests with cross-sensitivity to tenoxicam. J Dermatol Treatment 10:209–212

    Google Scholar 

  140. Kawada A, Kobayashi T, Noguchi H, Hiruma M, Ishibashi A, Marshall L (1996) Fixed drug eruption induced by sulfasalazine. Contact Dermatitis 34:155–156

    Article  PubMed  CAS  Google Scholar 

  141. van Ketel WG (1988) Systemic contact-type dermatitis by derivatives of adamantane? Derm Beruf Umwelt 36:23–24

    PubMed  Google Scholar 

  142. van den Berg WHHW, van Ketel WG (1983) Contactallergie voor ethyleendiamine. Ned Tijdschr Geneeskd 127:1801–1802

    PubMed  Google Scholar 

  143. Maibach HI (1987) Oral substitution in patients sensitized by transdermal clonidine treatment. Contact Dermatitis 16:1–8

    Article  PubMed  CAS  Google Scholar 

  144. Stingeni L, Caraffini S, Assolve D, Lapomarda V, Lisi P (1996) Erythema-multiforme-like contact dermatitis from budesonide. Contact Dermatitis 34:154–155

    Article  PubMed  CAS  Google Scholar 

  145. Isaksson M, Persson L-M (1998) Contact allergy to hydrocortisone and systemic contact dermatitis from prednisolone with tolerance of betamethasone. Am J Contact Dermatitis 9:136–138

    Article  PubMed  CAS  Google Scholar 

  146. McKenna DB, Murphy GM (1998) Contact allergy to topical corticosteroids and systemic allergy to prednisolone. Contact Dermatitis 38:121–122

    PubMed  CAS  Google Scholar 

  147. Valsecchi R, Reseghetti P, Leghissa P, Cologni L, Cortinovis R (1998) Erythema-multiforme-like lesions from triamcinolone acetonide. Contact Dermatitis 38:362–363

    PubMed  CAS  Google Scholar 

  148. Whitmore SE (1995) Delayed systemic allergic reactions to corticosteroids. Contact Dermatitis 32:193–198

    Article  PubMed  CAS  Google Scholar 

  149. Ash S, Scheman AJ (1997) Systemic contact dermatitis to hydroxyzine. Am J Contact Dermatitis 8:2–5

    Article  PubMed  CAS  Google Scholar 

  150. Nadal C, Pujol RM, Randazzo E, Alomar A (1996) Systemic contact dermatitis from 5-fluorouracil. Contact Dermatitis 35:124–125

    Article  PubMed  CAS  Google Scholar 

  151. Grob JJ, Mege JL, Follana J, Legre R, Andrac L, Bonerandi JJ (1990) Skin necrosis after injection of aminosides. Dermatologica 180:258–262

    Article  PubMed  CAS  Google Scholar 

  152. Möller H, Ohlsson K, Linder C, Björkner B, Bruze M (1998) Cytokines and acute phase reactants during flareup of contact allergy to gold. Am J Contact Dermat 9:15–22

    Article  PubMed  Google Scholar 

  153. Fleming C, Porter D, MacKie R (1998) Absence of gold sodium thiosulfate contact hypersensitivity in rheumatoid arthritis. Contact Dermatitis 38:55–56

    PubMed  CAS  Google Scholar 

  154. Krasovec M, Kämmerer R, Spertini F, Frenk E (1995) Contact dermatitis from heparin gel following sensitization by subcutaneous heparin administration. Contact Dermatitis 33:135–136

    Article  PubMed  CAS  Google Scholar 

  155. Silvestre JF, Alfonso R, Moragón M, Ramón R, Botella R (1997) Systemic contact dermatitis due to norfloxacin with a positive patch test to quinoline mix. Contact Dermatitis 39:83

    Google Scholar 

  156. Ekelund A-G, Möller H (1969) Oral provocation in eczematous contact allergy to neomycin and hydroxy-quinolines. Arch Derm Venereol (Stockh) 49:422–426

    CAS  Google Scholar 

  157. Michel M, Dompmartin A, Louvet S, Szczurko C, Castel B, Leroy D (1997) Skin reactions to hydroxyzine. Contact Dermatitis 36:147–149

    Article  PubMed  CAS  Google Scholar 

  158. Fernändez L, Maquiera E, Rodríguez F, Picans I, Duque S (1996) Systemic contact dermatitis from miconazole. Contact Dermatitis 34:217

    Article  PubMed  Google Scholar 

  159. Van Dijke CPH, Veerman FR, Haverkamp HCH (1983) Anaphylactic reactions to ketoconazole. Br Med J 287:1673

    Article  Google Scholar 

  160. Curley RK, Macfarlane AW, Kong CM (1986) Contact sensitivity to the amide anesthetics lidocaine, prilocaine, and mepivacaine. Case report and review of the literature. Arch Dermatol 122:924–926

    Article  PubMed  CAS  Google Scholar 

  161. Downs AMR, Lear JT, Wallington TB, Sanson JE (1998) Contact sensitivity and systemic reaction to pseudoephedrine and lignocaine. Contact Dermatitis 39:33

    PubMed  CAS  Google Scholar 

  162. Marques C, Faria E, Machado A, Gonçalo M, Gonçalo S (1995) Allergic contact dermatitis and systemic contact dermatitis from cinchocaine. Contact Dermatitis 33:443

    Article  PubMed  CAS  Google Scholar 

  163. Christensen OB (1990) Two cases of delayed hypersensitivity to mitomycin C following intravesicular chemotherapy of superficial bladder cancer. Contact Dermatitis 23:263

    Article  Google Scholar 

  164. de Groot AC, Conemans JM (1991) Systemic allergic contact dermatitis from intravesical instillation of the antitumor antibiotic mitomycin C. Contact Dermatitis 24:201–209

    Article  PubMed  Google Scholar 

  165. Echechipía S, Alvarez MJ, García BE, Olaguíbel JM, Rodriguez A, Lizaso MT, Acero S, Tabar AI (1995) Generalized dermatitis due to mitomycin C patch test. Contact Dermatitis 33:432

    Article  PubMed  Google Scholar 

  166. Barbaud A, Tréchot P, Aublet-Cuvelier A, Reichert-Penetrat S, Schmutz J-L (1998) Bufexamac and diclofenac: frequency of contact sensitization and absence of crossreactions. Contact Dermatitis 39:272–273

    PubMed  CAS  Google Scholar 

  167. Dooms-Goossens A, Dooms M, van Lint L, Degreef H (1979) Skin sensitizing properties of arylalcanoic acids and their analogues. Contact Dermatitis 5:324–328

    Article  PubMed  CAS  Google Scholar 

  168. Kerre S, Busschots A, Dooms-Goossens A (1995) Erythema-multiforme-like contact dermatitis due to phenylbutazone. Contact Dermatitis 33:213–214

    Article  PubMed  CAS  Google Scholar 

  169. Walchner M, Rueff F, Przybilla B (1997) Delayed-type hypersensitivity to mofebutazone underlying a severe drug reaction. Contact Dermatitis 36:54–55

    Article  PubMed  CAS  Google Scholar 

  170. Lechner T, Grytzmann B, Bäurle G (1987) Hämatogenes allergisches Kontaktekzem nach oraler Gabe von Nystatin. (Hematogenous allergic contact dermatitis after oral administration of nystatin) Mykosen 30:143–146

    PubMed  CAS  Google Scholar 

  171. Hemmer W, Bracun R, Wolf-Abdolvahab S, Focke M, Götz M, Jarisch R (1997) Maintenance of hand eczema by oral pantothenic acid in a patient sensitized to dexpanthenol. Contact Dermatitis 37:51

    Article  PubMed  CAS  Google Scholar 

  172. Giordano-Labadie F, Pech-Ormieres C, Bazex J (1996) Systemic contact dermatitis from sorbic acid. Contact Dermatitis 34:61–62

    Article  PubMed  CAS  Google Scholar 

  173. Michel M, Dompmartin A, Szczurko C, Castel B, Moreau A, Leroy D (1996) Eczematous-like drug eruption induced by synergistins. Contact Dermatitis 34:86–87

    Article  PubMed  CAS  Google Scholar 

  174. Zenerola P, Gimma A, Lomuto M (1995) Systemic contact dermatitis from thimerosal. Contact Dermatitis 32:107–108

    Article  Google Scholar 

  175. Fisher AA (1966) Systemic eczematous “contact-type” dermatitis medicamentosa. Ann Allergy 24:406–420

    PubMed  CAS  Google Scholar 

  176. Hom HM, Humphreys F, Aldridge RD (1998) Contact dermatitis and prolonged photosensitivity induced by ketoprofen and associated with sensitivity to benzophenone-3. Contact Dermatitis 38:353–354

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Free University Hospital, De Boelelaan, 1117, 1081 HV, Amsterdam, The Netherlands

    Derk P. Bruynzeel

  2. Rua Infanta D. Maria, No 30-30-A-3D, 3030-330, Coimbra, Portugal

    Margarida Gonçalo

Authors
  1. Derk P. Bruynzeel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Margarida Gonçalo
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinikum Dortmund gGmbH, Hautklinik Lehrstuhl Dermatologie der Universität Witten/Herdecke, Beurhausstr. 40, 44137, Dortmund, Germany

    Peter J. Frosch (Professor) (Professor)

  2. Dermatologisk afdeling K, Amtssygehuset Gentofte, 2900, Hellerup, Denmark

    Torkil Menné (Professor Dr.) (Professor Dr.)

  3. Laboratoire de Dermato-Chimie Clinique Dermatologique, CHU, 67091, Strasbourg Cedex, France

    Jean-Pierre Lepoittevin (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Bruynzeel, D.P., Gonçalo, M. (2006). Patch Testing in Adverse Drug Reactions. In: Frosch, P.J., Menné, T., Lepoittevin, JP. (eds) Contact Dermatitis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-31301-X_24

Download citation

  • DOI: https://doi.org/10.1007/3-540-31301-X_24

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-24471-4

  • Online ISBN: 978-3-540-31301-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation